• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    10/4/22 12:08:11 PM ET
    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials
    Get the next $ADIL alert in real time by email

     

    On Tuesday, 44 companies hit new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • Maravai LifeSciences (NASDAQ:MRVI) was the largest firm by market cap to set a new 52-week low.
    • The smallest company on a market cap basis to set a new 52-week low was Reshape Lifesciences (NASDAQ:RSLS).
    • Biohaven Pharma Hldgs (NYSE:BHVN) was the biggest loser of the morning session, as it dropped 94.89% to reach its new 52-week low.
    • Mobile Global Esports (NASDAQ:MGAM)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low.

    Here are all the stocks that set new 52-week lows on Tuesday:

    • Maravai LifeSciences (NASDAQ:MRVI) stock hit $19.82 on Tuesday morning, setting a new 52-week low for a change of down 12.23%.
    • Membership Collective (NYSE:MCG) stock hit $3.18 on Tuesday morning, setting a new 52-week low for a change of up 2.74%.
    • FaZe Holdings (NASDAQ:FAZE) stock broke to a new 52-week low of $4.91 on Tuesday. Shares of the company traded down 33.13%.
    • GigaCloud Tech (NASDAQ:GCT) shares reached a new 52-week low of $7.61 on Tuesday morning, moving down 4.37%.
    • Starry Group Holdings (NYSE:STRY) shares reached a new 52-week low of $1.29 on Tuesday morning, moving up 2.69%.
    • Nuveen Inter Dur Quality (NYSE:NIQ) shares fell to $11.94 on Tuesday, setting a new 52-week low with a shift of down 1.14%.
    • KalVista Pharma (NASDAQ:KALV) stock hit a yearly low of $6.00. The stock was down 55.9% for the day.
    • Verastem (NASDAQ:VSTM) shares made a new 52-week low of $0.63 on Tuesday. The stock was down 27.19% for the day.
    • Clene (NASDAQ:CLNN) shares were down 7.46% for the day, having made a 52-week low of $1.70.
    • Lument Finance Trust (NYSE:LFT) shares fell to $2.13 on Tuesday, setting a new 52-week low with a shift of up 1.4%.
    • Linkbancorp (NASDAQ:LNKB) stock achieved a new 52-week low on Tuesday morning, hitting $7.35 and moving up 0.6%.
    • Vertical Capital Income (NYSE:VCIF) stock drifted down 0.11% on Tuesday morning to hit a new 52-week low of $8.70.
    • Biora Therapeutics (NASDAQ:BIOR) shares moved down 0.52% on Tuesday to hit a new 52-week low of $0.46, drifting down 0.52%.
    • Addentax Group (NASDAQ:ATXG) shares fell to $2.60 on Tuesday, setting a new 52-week low with a shift of up 2.3%.
    • Cardiol Therapeutics (NASDAQ:CRDL) stock set a new 52-week low of $0.97 on Tuesday, moving down 0.08%.
    • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares fell to $3.81 on Tuesday, setting a new 52-week low with a shift of up 3.84%.
    • Gaia (NASDAQ:GAIA) stock dropped to a yearly low on Tuesday of $2.41. Shares traded down 0.4%.
    • Sky Harbour Group (AMEX:SKYH) shares moved down 0.45% on Tuesday to hit a new 52-week low of $3.32, drifting down 0.45%.
    • icad (NASDAQ:ICAD) stock drifted up 6.1% on Tuesday morning to hit a new 52-week low of $1.87.
    • Augmedix (NASDAQ:AUGX) stock broke to a new 52-week low of $1.33 on Tuesday. Shares of the company traded down 3.57%.
    • Delwinds Insurance (AMEX:FOXO) stock hit a new 52-week low of $1.10. The stock was down 8.66% on the session.
    • Mobile Global Esports (NASDAQ:MGAM) shares moved 0.0% (flat) on Tuesday to hit a new 52-week low of $1.72, drifting 0.0% (flat).
    • Ecoark Hldgs (NASDAQ:ZEST) stock hit $0.99 on Tuesday morning, setting a new 52-week low for a change of down 4.76%.
    • Cocrystal Pharma (NASDAQ:COCP) shares reached a new 52-week low of $0.26 on Tuesday morning, moving down 11.75%.
    • Quanergy Systems (NYSE:QNGY) shares reached a new 52-week low of $0.15 on Tuesday morning, moving down 14.95%.
    • VIQ Solutions (NASDAQ:VQS) shares were up 5.29% for the day, having made a 52-week low of $0.58.
    • mCloud Technologies (NASDAQ:MCLD) stock dropped to a yearly low on Tuesday of $1.21. Shares traded down 7.36%.
    • Air Industries (AMEX:AIRI) stock hit a new 52-week low of $0.55. The stock was down 9.13% on the session.
    • Carver Bancorp (NASDAQ:CARV) shares reached a new 52-week low of $3.85 on Tuesday morning, moving up 2.04%.
    • iMedia Brands (NASDAQ:IMBI) stock achieved a new 52-week low on Tuesday morning, hitting $0.55 and moving up 0.56%.
    • Rail Vision (NASDAQ:RVSN) stock dropped to a yearly low on Tuesday of $0.55. Shares traded up 3.32%.
    • Adial Pharmaceuticals (NASDAQ:ADIL) stock set a new 52-week low of $0.34 on Tuesday, moving up 0.73%.
    • SINTX Technologies (NASDAQ:SINT) shares moved up 1.67% on Tuesday to hit a new 52-week low of $0.29, drifting up 1.67%.
    • ComSovereign Holding (NASDAQ:COMS) shares hit a yearly low of $0.07. The stock was down 2.62% on the session.
    • Dunxin Financial Hldgs (AMEX:DXF) shares set a new 52-week low of $0.24. The stock traded down 8.14%.
    • Reshape Lifesciences (NASDAQ:RSLS) stock broke to a new 52-week low of $0.28 on Tuesday. Shares of the company traded up 3.84%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $AIRI
    $AUGX
    $BHVN

    CompanyDatePrice TargetRatingAnalyst
    Biohaven Ltd.
    $BHVN
    2/6/2026$23.00Buy
    Goldman
    Verastem Inc.
    $VSTM
    2/4/2026$18.00Buy
    H.C. Wainwright
    Biohaven Ltd.
    $BHVN
    1/21/2026$22.00Sector Perform → Outperform
    RBC Capital Mkts
    KalVista Pharmaceuticals Inc.
    $KALV
    1/9/2026$32.00 → $35.00Buy
    Needham
    KalVista Pharmaceuticals Inc.
    $KALV
    1/6/2026$28.00 → $32.00Buy
    Needham
    Biohaven Ltd.
    $BHVN
    12/3/2025$11.00Buy → Neutral
    H.C. Wainwright
    Biohaven Ltd.
    $BHVN
    11/26/2025$11.00Buy → Neutral
    UBS
    Biohaven Ltd.
    $BHVN
    11/6/2025$9.00Outperform → Mkt Perform
    Bernstein
    More analyst ratings

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Biohaven with a new price target

    Goldman initiated coverage of Biohaven with a rating of Buy and set a new price target of $23.00

    2/6/26 8:10:57 AM ET
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    H.C. Wainwright initiated coverage on Verastem with a new price target

    H.C. Wainwright initiated coverage of Verastem with a rating of Buy and set a new price target of $18.00

    2/4/26 8:31:21 AM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Biohaven upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Biohaven from Sector Perform to Outperform and set a new price target of $22.00

    1/21/26 8:29:40 AM ET
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

    Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial 1-800-343-4136 or 1-203-518-9843 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com. About Maravai M

    2/9/26 5:05:00 PM ET
    $MRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rail Vision Advances Strategic Collaboration with Israel Railways Cargo Division

    With its MainLine product already installed on Israel Railways' locomotives, this collaboration aims to expand Rail Vision's product offering by deploying its ShuntingYard product within Israel Railways' cargo division Ra'anana, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, announced today its advancement to the next phase of its collaboration with Israel Railways. As previously announced, Israel Railways purchased and installed Rail Vision's MainLine systems on its locomotives and this advancement marks the

    2/6/26 8:32:00 AM ET
    $RVSN
    Railroads
    Industrials

    Rail Vision: Quantum Transportation Unveils Transformer Neural Decoder That Outperforms Classical QEC Algorithms in Simulations

    Simulation results show enhanced logical error suppression and real-time decoding potential Ra'anana, Israel, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, recently announced that its majority owned subsidiary Quantum Transportation Ltd. ("Quantum Transportation"), a quantum computing innovator, has achieved a major technical breakthrough with the successful prototype development and rigorous validation of its first-generation transformer-based neural decoder - a pioneering, code-agnostic solution designed to advance

    2/5/26 8:28:00 AM ET
    $RVSN
    Railroads
    Industrials

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Biohaven Ltd.

    SCHEDULE 13G/A - Biohaven Ltd. (0001935979) (Subject)

    2/6/26 4:31:28 PM ET
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Rail Vision Ltd.

    6-K - Rail Vision Ltd. (0001743905) (Filer)

    2/6/26 4:00:21 PM ET
    $RVSN
    Railroads
    Industrials

    SEC Form 424B3 filed by Gaia Inc.

    424B3 - GAIA, INC (0001089872) (Filer)

    2/5/26 4:44:41 PM ET
    $GAIA
    Movies/Entertainment
    Consumer Discretionary

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Frost Phillip Md Et Al bought $47,280 worth of shares (50,000 units at $0.95) (SEC Form 4)

    4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)

    2/9/26 4:10:05 PM ET
    $COCP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Keenan Walter C bought $36,448 worth of shares (25,000 units at $1.46) (SEC Form 4)

    4 - Lument Finance Trust, Inc. (0001547546) (Issuer)

    1/8/26 8:46:07 AM ET
    $LFT
    Real Estate Investment Trusts
    Real Estate

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Frost Phillip Md Et Al bought $47,280 worth of shares (50,000 units at $0.95) (SEC Form 4)

    4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)

    2/9/26 4:10:05 PM ET
    $COCP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Paterson Dan sold $6,489 worth of shares (970 units at $6.69), decreasing direct ownership by 0.16% to 612,919 units (SEC Form 4)

    4 - Verastem, Inc. (0001526119) (Issuer)

    2/5/26 4:10:10 PM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Ugwumba Chidozie sold $22,792 worth of shares (5,559 units at $4.10) (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    2/5/26 10:18:03 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Leadership Updates

    Live Leadership Updates

    View All

    Verastem Oncology Announces Strategic Transition Plan to Accelerate Next Phase of Growth

    John Johnson, current board member, appointed to chairman of the board Michael Kauffman, M.D., Ph.D., lead director since 2016, appointed to president of development Commercial launch progresses as RAMP 301 Phase 3 confirmatory trial in recurrent LGSOC completes additional patient enrollment; topline data anticipated in mid-2027 Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced strategic leadership changes to accelerate its next phase of growth. Michael Kauffman, M.D., Ph.D., currently lead director of the Board, has been appointed as the president of development and will jo

    12/15/25 4:01:00 PM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Carver Bancorp, Inc. Commences Trading on OTC Markets

    Stockholders can access price quotes and volume data at www.OTCmarkets.com and on other public platformsTransition paves the way for increased flexibility to improve operational excellence, accelerate growth and enhance capital positionManagement and Board remain focused on transforming Carver to position it for success and continue to pursue strategy to drive long-term, sustainable profitabilityNEW YORK, Dec. 8, 2025 /PRNewswire/ -- Carver Bancorp, Inc. (the "Company") (OTCQB:CARV), the holding company for Carver Federal Savings Bank, reminds stockholders that, as of today, the Company's common stock trades on the OTC Markets under the ticker "CARV".

    12/8/25 8:00:00 AM ET
    $CARV
    Savings Institutions
    Finance

    Carver Bancorp, Inc. Announces Board Modernization Initiative with Comprehensive Governance Enhancements

    Governance changes are designed to align Carver's board policies with leading companies, reinforcing the board's fiduciary commitment to all shareholders.The modernization plan includes a 75% turnover rate among directors over the next 3 years and the implementation of enhanced skills-based recruitment.Restructured equity-based compensation preserves capital flexibility while aligning directors' interests with long-term value creation and increased ownership stakes.The initiative builds on the recent appointment of Jason Sisack, former OCC Assistant Deputy Comptroller, with more than 25 years of regulatory expertise in governance and risk management, as an advisor to the Chief Executive Offi

    11/5/25 8:30:00 AM ET
    $CARV
    Savings Institutions
    Finance

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Financials

    Live finance-specific insights

    View All

    Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026

    Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call by telephone, dial 1-800-343-4136 or 1-203-518-9843 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com. About Maravai M

    2/9/26 5:05:00 PM ET
    $MRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Carver Bancorp, Inc. Announces Date of Annual Meeting of Stockholders

    NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Carver Bancorp, Inc. (the "Company") (OTCQB:CARV), the holding company for Carver Federal Savings Bank, today announced that its Annual Meeting of Stockholders (the "Annual Meeting") will take place on May 21, 2026. The Company will provide additional details regarding the Annual Meeting in due course. In addition, stockholders wishing to bring business before the Annual Meeting or to nominate a person for election to the board of directors of the Company (the "Board") at the Annual Meeting must submit timely notice thereof to the Compan

    1/20/26 8:00:00 AM ET
    $CARV
    Savings Institutions
    Finance

    Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

    NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Lument Finance Trust, Inc. (NYSE: LFT) ("LFT" or the "Company") announced the declaration of a cash dividend of $0.04 per share of common stock with respect to the fourth quarter of 2025. The dividend is payable on January 15, 2026, to common stockholders of record as of the close of business on December 31, 2025. The Company also announced the declaration of a cash dividend of $0.4921875 per share of 7.875% Cumulative Redeemable Series A Preferred Stock. The dividend is payable on January 15, 2026 to preferred stockholders of record as of the close of business January 2, 2026. About LFT LFT is a Maryland corporation focused on investing in, financing

    12/11/25 5:15:00 PM ET
    $LFT
    Real Estate Investment Trusts
    Real Estate

    $ADIL
    $AIRI
    $AUGX
    $BHVN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carver Bancorp Inc.

    SC 13D/A - CARVER BANCORP INC (0001016178) (Subject)

    12/12/24 5:00:53 PM ET
    $CARV
    Savings Institutions
    Finance

    Amendment: SEC Form SC 13G/A filed by Maravai LifeSciences Holdings Inc.

    SC 13G/A - MARAVAI LIFESCIENCES HOLDINGS, INC. (0001823239) (Subject)

    11/14/24 7:49:19 PM ET
    $MRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by SiNtx Technologies Inc.

    SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

    11/14/24 7:25:52 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care